Literature DB >> 28843823

Inhibitory and bactericidal effect of Artilysin® Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates.

Eva Schirmeier1, Pia Zimmermann2, Veronika Hofmann1, Manfred Biebl1, Hans Gerstmans3, Veerle E T Maervoet4, Yves Briers5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28843823     DOI： 10.1016/j.ijantimicag.2017.08.027

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  12 in total

Review 1.  The rise and spread of mcr plasmid-mediated polymyxin resistance.

Authors:  Sue C Nang; Jian Li; Tony Velkov
Journal:  Crit Rev Microbiol       Date:  2019-05-23       Impact factor: 7.624

Review 2.  Managing urinary tract infections through phage therapy: a novel approach.

Authors:  Shikha Malik; Parveen Kaur Sidhu; J S Rana; Kiran Nehra
Journal:  Folia Microbiol (Praha)       Date:  2019-09-07       Impact factor: 2.099

3.  Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.

Authors:  Karim Abdelkader; Diana Gutiérrez; Héctor Tamés-Caunedo; Patricia Ruas-Madiedo; Amal Safaan; Ahmed S Khairalla; Yasser Gaber; Tarek Dishisha; Yves Briers
Journal:  Appl Environ Microbiol       Date:  2021-10-20       Impact factor: 5.005

4.  Antibacterial Activity of a Lytic Enzyme Encoded by Pseudomonas aeruginosa Double Stranded RNA Bacteriophage phiYY.

Authors:  Yuhui Yang; Shuai Le; Wei Shen; Qian Chen; Youying Huang; Shuguang Lu; Yinling Tan; Ming Li; Fuquan Hu; Yang Li
Journal:  Front Microbiol       Date:  2018-08-03       Impact factor: 5.640

Review 5.  Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.

Authors:  Carlos São-José
Journal:  Antibiotics (Basel)       Date:  2018-03-22

6.  Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection.

Authors:  Alexandra G Fraga; Gabriela Trigo; Ramya K Murthy; Shamim Akhtar; Madhavi Hebbur; Ana Rita Pacheco; Juan Dominguez; Rita Silva-Gomes; Carine M Gonçalves; Hugo Oliveira; António G Castro; Umender Sharma; Joana Azeredo; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2019-08-19

Review 7.  An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review.

Authors:  Mohammad H Gharaibeh; Shoroq Q Shatnawi
Journal:  Vet World       Date:  2019-11-08

Review 8.  Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria.

Authors:  Seyed Mohammad Mousavi; Sajad Babakhani; Leila Moradi; Saina Karami; Mahsa Shahbandeh; Maryam Mirshekar; Samane Mohebi; Majid Taati Moghadam
Journal:  Curr Microbiol       Date:  2021-10-11       Impact factor: 2.343

Review 9.  How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections.

Authors:  Aditi Singh; Sudhakar Padmesh; Manish Dwivedi; Irena Kostova
Journal:  Infect Drug Resist       Date:  2022-02-17       Impact factor: 4.003

10.  Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.

Authors:  Athina Zampara; Martine C Holst Sørensen; Dennis Grimon; Fabio Antenucci; Amira Ruslanovna Vitt; Valeria Bortolaia; Yves Briers; Lone Brøndsted
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.